Alternative angiogenesis mechanisms in uterine fibroids related to heavy menstrual bleeding

被引：0
|
作者：
Subramaniam, K. S. [1 ]
Tapmeier, T. [1 ]
Wang, C-Y [1 ]
O'Brien, D. [1 ]
Philpott, M. [1 ]
Manek, S. [2 ]
Lindenthal, B. [3 ]
Obendorf, M. [3 ]
de Leo, B. [3 ]
Hess-Stumpp, H. [3 ]
Zollner, T. [3 ]
Macaulay, V [1 ]
Kessler, B. [1 ]
Zondervan, K. [1 ,4 ]
Oppermann, U. [1 ]
Harris, A. [1 ]
Becker, C. [1 ]
机构：
[1] Univ Oxford, Oxford, England
[2] Oxford Univ Hosp Fdn Trust, Oxford, England
[3] Bayer AG, Berlin, Germany
[4] Wellcome Trust Ctr Human Genet, Oxford, England
来源：
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2019年 / 126卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
0012
引用
收藏
页码：E125 / E126
页数：2
相关论文
共 50 条
  • [31] Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids
    Al-Hendy, Ayman
    Bradley, Linda
    Owens, Charlotte D.
    Wang, Hui
    Barnhart, Kurt T.
    Feinberg, Eve
    Schlaff, William D.
    Puscheck, Elizabeth E.
    Wang, Alice
    Gillispie, Veronica
    Hurtado, Sandra
    Muneyyirci-Delale, Ozgul
    Archer, David F.
    Carr, Bruce R.
    Simon, James A.
    Stewart, Elizabeth A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (01)
  • [32] Elagolix Improves Quality of Life Among Uterine Fibroids Patients With Heavy Menstrual Bleeding in Phase III Trials
    Al-Hendy, Ayman
    Soliman, Ahmed M.
    Wang, Hui
    Coyne, Karin
    Carr, Bruce R.
    OBSTETRICS AND GYNECOLOGY, 2019, 133 : 149S - 149S
  • [33] Reduction of Heavy Menstrual Bleeding in Women Not Designated as Responders to Elagolix Plus Add Back Therapy for Uterine Fibroids
    Stewart, Elizabeth A.
    Archer, David F.
    Owens, Charlotte D.
    Barnhart, Kurt T.
    Bradley, Linda D.
    Feinberg, Eve C.
    Gillispie-Bell, Veronica
    Imudia, Anthony N.
    Liu, Ran
    Kim, Jin Hee
    Al-Hendy, Ayman
    JOURNAL OF WOMENS HEALTH, 2022, 31 (05) : 698 - 705
  • [34] Elagolix Reduced Heavy Menstrual Bleeding With Uterine Fibroids: Primary, 6-Month, Phase 3 Results
    Schlaff, William
    Al-Hendy, Ayman
    Barnhart, Kurt
    Owens, Charlotte D.
    Liu, Ran
    Muneyyirci-Delale, Ozgul
    OBSTETRICS AND GYNECOLOGY, 2019, 133 : 9S - 9S
  • [35] MEASURING PATIENT-REPORTED OUTCOMES IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS: THE BLEEDING AND PELVIC DISCOMFORT SCALE.
    Li, Juliet
    Kang, Jennifer B.
    Hunsche, Elke
    Hudgens, Stacie
    FERTILITY AND STERILITY, 2019, 112 (03) : E344 - E344
  • [36] Angiogenesis mediators in women with idiopathic heavy menstrual bleeding
    Elkilani, Osama A.
    Soliman, Mohamed A.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2017, 136 (03) : 280 - 284
  • [37] The modern management of uterine fibroids-related abnormal uterine bleeding
    Vannuccini, Silvia
    Petraglia, Felice
    Carmona, Francisco
    Calaf, Joaquim
    Chapron, Charles
    FERTILITY AND STERILITY, 2024, 122 (01) : 20 - 30
  • [38] Ulipristal acetate for the management of acute heavy menstrual bleeding without fibroids
    Estadella, Josep
    Espanol, Pia
    Ascencio, Fiorella
    Perello, Josep
    Calaf, Joaquim
    GYNECOLOGICAL ENDOCRINOLOGY, 2018, 34 (07) : 554 - 557
  • [39] Medical therapies for heavy menstrual bleeding in women with uterine fibroids: a retrospective analysis of a large commercially insured population in the USA
    Yao, X.
    Stewart, E. A.
    Laughlin-Tommaso, S. K.
    Heien, H. C.
    Borah, B. J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 124 (02) : 322 - 330
  • [40] A 12-month extension study to evaluate the safety and efficacy of asoprisnil in women with heavy menstrual bleeding and uterine fibroids
    Diamond, M. P.
    Stewart, E. A.
    Williams, A. R. W.
    Carr, B. R.
    Myers, E. R.
    Feldman, R. A.
    Elger, W.
    Mattia-Goldberg, C.
    Schwefel, B. M.
    Chwalisz, K.
    HUMAN REPRODUCTION OPEN, 2019, 2019 (04)
12345